This site is intended for healthcare professionals
News

Phase III DAPA-CKD trial of Farxiga shows efficacy in chronic kidney disease.- AstraZeneca

Read time: 1 mins
Last updated:26th Oct 2020
Published:26th Oct 2020
Condition: Chronic Kidney Disease/CKD
Type: drug
Register free for full access to medthority.com